Lebrikizumab for dermatitis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Eczema

Why this status

  1. 21 Apr 2026: Trial registered, NCT07542483
  2. 24 Apr 2026: Trial started, NCT07542483

The trials

NCT07542483: A Study of Lebrikizumab in Adults With Nummular Eczema

State
Under way
Phase
Phase 3
People
270 planned
Started
24 Apr 2026
Primary completion
Aug 2028
Arms
Placebo-controlled Period: Lebrikizumab, Blinded Extension Period: Lebrikizumab, Blinded Extension Period: Lebrikizumab + Placebo
Results
None posted
  1. 21 Apr 2026: Trial registered
  2. 24 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.